Bioinformatics in Cancer Diagnostics and Screening
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Informatics and Big Data".
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 11675
Special Issue Editor
Interests: hereditary diseases; variant interpretation; splicing regulation; cancer genetics
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Over the last few years, the growing knowledge on cancer genetics and molecular bases has changed the way physicians, researchers, and patients approach cancer diagnosis and treatment. The use of bioinformatics in cancer diagnostics and screening represents a very recent development and an emerging field which combines omics-based technologies, artificial intelligence, and clinical and computational sciences.
The integration of clinical information with molecular profiling is improving cancer diagnosis, therapies, and prognosis. Bioinformatics in cancer is expected to play a pivotal role in the identification and validation of cancer biomarkers and its association with specific clinical phenotypes, including disease progression monitoring, response to therapy, and accurate prognosis prediction.
These recent findings are translating “precision medicine” into a routine practice for all professionals in the field and are improving cancer patients’ quality of life.
“Bioinformatics in Cancer Diagnostics and Screening” calls for papers dealing with the development of novel methods to diagnose and screen for human cancers using bioinformatics, machine (deep) learning, neural networks, processing and analysis of biological data, and anticancer drug discovery and design. This SI aims to collect works that have successfully translated into clinical practice or have high chances of becoming clinically relevant.
Prof. Dr. Alessandro Stella
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- bioinformatics
- cancer diagnosis
- cancer screening
- biomarkers
- precision medicine
- omics mass screening
- drug design